dcsimg

Antibiogram of Biofield-Treated Shigella boydii: Global Burden of Infections

provided by EOL authors

Abstract:

Bacillary dysentery and acute gastroenteritis caused by infection of Shigella species are major public health burden in India and its neighboring countries. Emergence of antimicrobial resistance threatens to render current treatments ineffective. The current study was attempted to investigate the effect of biofield treatment on Shigella boydii (S. boydii) with respect of antimicrobial susceptibility assay, biochemical characteristics and biotyping. The American Type Culture Collection (ATCC 9207) strain of S. boydii was used in this experiment. The study was conducted in revived and lyophilized state of S. boydii. Both revived (Group; Gr. II) and lyophilized (Gr. III) strain of S. boydii were subjected to Mr. Trivedi’s biofield treatment. Gr. II was assessed on day 5 and day 10, while Gr. III on day 10 with respect to control (Gr. I). Sensitivity pattern of amoxicillin/k-clavulanate was improved from intermediate (I) to susceptible (S) with correspond to MIC value was also reduced by two folds (16/8 to ≤ 8/4 μg/mL) in both the treated groups as compared to control. The antimicrobial susceptibility of S. boydii showed 15% alteration in Gr. II on day 5, while significant (40%) alteration was found on day 10 as compared to control. The MIC values of antimicrobials for S. boydii also showed 12.50% alteration in Gr. II on day 5 while, significant alteration (59.38%) of minimum inhibitory concentration (MIC) value was found in Gr. II on day 10 as compared to control. It was observed that overall 69.70% biochemical reactions were changed in which 66.67% alteration was found in Gr. II on day 10 with respect to control. Moreover, biotype numbers were changed in all the treated groups without alteration of organism as compared to control. These results suggested that biofield treatment had significant impact on S. boydii in Gr. II on day 10 with respect to antimicrobial susceptibility, MIC and biochemical reactions pattern.

license
cc-by-4.0
copyright
Trivedi Global Inc.
bibliographic citation
Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Sambhu Charan Mondal, Snehasis Jana. Antibiogram of BiofieldTreated Shigella boydii: Global Burden of Infections. Science Journal of Clinical Medicine. Vol. 4, No. 6, 2015, pp. 121-126. doi: 10.11648/j.sjcm.20150406.12
author
Mahendra Trivedi (MahendraTrivedi)
original
visit source
partner site
EOL authors

Antibiogram of Biofield-Treated Shigella boydii: Global Burden of Infections

provided by EOL authors
Bacillary dysentery and acute gastroenteritis caused by infection of Shigella species are major public health burden in India and its neighboring countries. Emergence of antimicrobial resistance threatens to render current treatments ineffective. The current study was attempted to investigate the effect of biofield treatment on Shigella boydii (S. boydiii) with respect of antimicrobial susceptibility assay, biochemical characteristics and biotyping. The American Type Culture Collection (ATCC 9207) strain of S. boydiii was used in this experiment. The study was conducted in revived and lyophilized state of S. boydiii. Both revived (Group; Gr. II) and lyophilized (Gr. III) strain of S. boydiii were subjected to Mr. Trivedi’s biofield treatment. Gr. II was assessed on day 5 and day 10, while Gr. III on day 10 with respect to control (Gr. I). Sensitivity pattern of amoxicillin/k-clavulanate was improved from intermediate (I) to susceptible (S) with correspond to MIC value was also reduced by two folds (16/8 to ≤ 8/4 μg/mL) in both the treated groups as compared to control. The antimicrobial susceptibility of S. boydiii showed 15% alteration in Gr. II on day 5, while significant (40%) alteration was found on day 10 as compared to control. The MIC values of antimicrobials for S. boydiii also showed 12.50% alteration in Gr. II on day 5 while, significant alteration (59.38%) of minimum inhibitory concentration (MIC) value was found in Gr. II on day 10 as compared to control. It was observed that overall 69.70% biochemical reactions were changed in which 66.67% alteration was found in Gr. II on day 10 with respect to control. Moreover, biotype numbers were changed in all the treated groups without alteration of organism as compared to control. These results suggested that biofield treatment had significant impact on S. boydiii in Gr. II on day 10 with respect to antimicrobial susceptibility, MIC and biochemical reactions pattern.
license
cc-by-4.0
copyright
Trivedi Global Inc.
bibliographic citation
Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Sambhu Charan Mondal, Snehasis Jana. Antibiogram of BiofieldTreated Shigella boydii: Global Burden of Infections. Science Journal of Clinical Medicine. Vol. 4, No. 6, 2015, pp. 121-126. doi: 10.11648/j.sjcm.20150406.12
author
Alice Branton (AliceBranton)
original
visit source
partner site
EOL authors

Antibiogram of Biofield-Treated Shigella boydii: Global Burden of Infections

provided by EOL authors
Bacillary dysentery and acute gastroenteritis caused by infection of Shigella species are major public health burden in India and its neighboring countries. Emergence of antimicrobial resistance threatens to render current treatments ineffective. The current study was attempted to investigate the effect of biofield treatment on Shigella boydii (S. boydiii) with respect of antimicrobial susceptibility assay, biochemical characteristics and biotyping. The American Type Culture Collection (ATCC 9207) strain of S. boydiii was used in this experiment. The study was conducted in revived and lyophilized state of S. boydiii. Both revived (Group; Gr. II) and lyophilized (Gr. III) strain of S. boydiii were subjected to Mr. Trivedi’s biofield treatment. Gr. II was assessed on day 5 and day 10, while Gr. III on day 10 with respect to control (Gr. I). Sensitivity pattern of amoxicillin/k-clavulanate was improved from intermediate (I) to susceptible (S) with correspond to MIC value was also reduced by two folds (16/8 to ≤ 8/4 μg/mL) in both the treated groups as compared to control. The antimicrobial susceptibility of S. boydiii showed 15% alteration in Gr. II on day 5, while significant (40%) alteration was found on day 10 as compared to control. The MIC values of antimicrobials for S. boydiii also showed 12.50% alteration in Gr. II on day 5 while, significant alteration (59.38%) of minimum inhibitory concentration (MIC) value was found in Gr. II on day 10 as compared to control. It was observed that overall 69.70% biochemical reactions were changed in which 66.67% alteration was found in Gr. II on day 10 with respect to control. Moreover, biotype numbers were changed in all the treated groups without alteration of organism as compared to control. These results suggested that biofield treatment had significant impact on S. boydiii in Gr. II on day 10 with respect to antimicrobial susceptibility, MIC and biochemical reactions pattern.
license
cc-by-4.0
copyright
Trivedi Global Inc.
bibliographic citation
Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Sambhu Charan Mondal, Snehasis Jana. Antibiogram of BiofieldTreated Shigella boydii: Global Burden of Infections. Science Journal of Clinical Medicine. Vol. 4, No. 6, 2015, pp. 121-126. doi: 10.11648/j.sjcm.20150406.12
author
Dahryn Trivedi (DahrynTrivedi)
original
visit source
partner site
EOL authors

Antibiogram of Biofield-Treated Shigella boydii: Global Burden of Infections

provided by EOL authors
Bacillary dysentery and acute gastroenteritis caused by infection of Shigella species are major public health burden in India and its neighboring countries. Emergence of antimicrobial resistance threatens to render current treatments ineffective. The current study was attempted to investigate the effect of biofield treatment on Shigella boydii (S. boydiii) with respect of antimicrobial susceptibility assay, biochemical characteristics and biotyping. The American Type Culture Collection (ATCC 9207) strain of S. boydiii was used in this experiment. The study was conducted in revived and lyophilized state of S. boydiii. Both revived (Group; Gr. II) and lyophilized (Gr. III) strain of S. boydiii were subjected to Mr. Trivedi’s biofield treatment. Gr. II was assessed on day 5 and day 10, while Gr. III on day 10 with respect to control (Gr. I). Sensitivity pattern of amoxicillin/k-clavulanate was improved from intermediate (I) to susceptible (S) with correspond to MIC value was also reduced by two folds (16/8 to ≤ 8/4 μg/mL) in both the treated groups as compared to control. The antimicrobial susceptibility of S. boydiii showed 15% alteration in Gr. II on day 5, while significant (40%) alteration was found on day 10 as compared to control. The MIC values of antimicrobials for S. boydiii also showed 12.50% alteration in Gr. II on day 5 while, significant alteration (59.38%) of minimum inhibitory concentration (MIC) value was found in Gr. II on day 10 as compared to control. It was observed that overall 69.70% biochemical reactions were changed in which 66.67% alteration was found in Gr. II on day 10 with respect to control. Moreover, biotype numbers were changed in all the treated groups without alteration of organism as compared to control. These results suggested that biofield treatment had significant impact on S. boydiii in Gr. II on day 10 with respect to antimicrobial susceptibility, MIC and biochemical reactions pattern.
license
cc-by-4.0
copyright
Trivedi Global Inc.
bibliographic citation
Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Sambhu Charan Mondal, Snehasis Jana. Antibiogram of BiofieldTreated Shigella boydii: Global Burden of Infections. Science Journal of Clinical Medicine. Vol. 4, No. 6, 2015, pp. 121-126. doi: 10.11648/j.sjcm.20150406.12
author
Gopal Nayak (GopalNayak)
original
visit source
partner site
EOL authors

Shigella boydii

provided by wikipedia EN

Shigella boydii is a Gram-negative bacterium of the genus Shigella. Like other members of the genus, S. boydii is a nonmotile, nonsporeforming, rod-shaped bacterium which can cause dysentery in humans through fecal-oral contamination.[1]

Shigella boydii is the most genetically divergent species of the genus Shigella.[2] There are 19 known serotypes of Shigella boydii.[3][4][5] S. boydii is restricted to the Indian subcontinent.[4]

The species is named after the British bacteriologist John Boyd.[6]

Sequenced genomes

  • Shigella boydii strain BS512 (serotype 18; group 1) has one chromosome and five plasmids.

References

  1. ^ Ryan, Kenneth James; Ray, C. George, eds. (2004). Sherris medical microbiology: an introduction to infectious diseases (4 ed.). McGraw-Hill Professional Med/Tech. ISBN 978-0-8385-8529-0.
  2. ^ Feng L; Senchenkova SN; Yang J; Shashkov AS; Tao J; Guo H; Zhao G; Knirel YA; Reeves P; Wang L (2004). "Structural and Genetic Characterization of the Shigella boydii Type 13 O Antigen". Journal of Bacteriology. 186 (2): 383–392. doi:10.1128/JB.186.2.383-392.2004. PMC 305744. PMID 14702307.
  3. ^ Yang Z., Hu C., Chen J., Chen G., Liu Z. (1990). A new serotype of Shigella boydii. Wei Sheng Wu Xue Bao.; 30(4): 284-95
  4. ^ a b Yang F, Yang J, Zhang X, et al. (2005). "Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery". Nucleic Acids Research. 33 (19): 6445–6458. doi:10.1093/nar/gki954. PMC 1278947. PMID 16275786.
  5. ^ Pupo GM; Lan R; Reeves PR (September 2000). "Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics". Proc. Natl. Acad. Sci. U.S.A. 97 (19): 10567–72. Bibcode:2000PNAS...9710567P. doi:10.1073/pnas.180094797. PMC 27065. PMID 10954745.
  6. ^ "Species: Shigella boydii". lpsn.dsmz.de. Retrieved 2022-08-19.

license
cc-by-sa-3.0
copyright
Wikipedia authors and editors
original
visit source
partner site
wikipedia EN

Shigella boydii: Brief Summary

provided by wikipedia EN

Shigella boydii is a Gram-negative bacterium of the genus Shigella. Like other members of the genus, S. boydii is a nonmotile, nonsporeforming, rod-shaped bacterium which can cause dysentery in humans through fecal-oral contamination.

Shigella boydii is the most genetically divergent species of the genus Shigella. There are 19 known serotypes of Shigella boydii. S. boydii is restricted to the Indian subcontinent.

The species is named after the British bacteriologist John Boyd.

license
cc-by-sa-3.0
copyright
Wikipedia authors and editors
original
visit source
partner site
wikipedia EN